You are here » Home » Companies » Company Overview » Everest Organics Ltd

Everest Organics Ltd.

BSE: 524790 Sector: Health care
NSE: N.A. ISIN Code: INE334C01029
BSE LIVE 13:58 | 22 Sep 114.80 0
(0.00%)
OPEN

114.80

HIGH

114.80

LOW

112.00

NSE 05:30 | 01 Jan Stock Is Not Traded.
OPEN 114.80
PREVIOUS CLOSE 114.80
VOLUME 7454
52-Week high 114.80
52-Week low 44.45
P/E 55.46
Mkt Cap.(Rs cr) 92
Buy Price 114.80
Buy Qty 913.00
Sell Price 0.00
Sell Qty 0.00
OPEN 114.80
CLOSE 114.80
VOLUME 7454
52-Week high 114.80
52-Week low 44.45
P/E 55.46
Mkt Cap.(Rs cr) 92
Buy Price 114.80
Buy Qty 913.00
Sell Price 0.00
Sell Qty 0.00

Everest Organics Ltd. (EVERESTORGANICS) - Director Report

Company director report

To

The Members

Everest Organics Limited

CIN : L24230AP1993015426

Your Directors have pleasure in presenting the 23rd Annual Report of the Companytogether with the Audited Statement of Accounts for the year ended 31st March 2016.

1. FINANCIAL STATEMENTS & RESULTS:

a. Financial Results

The Company's performance during the year ended 31st March 2016 as compared to theprevious financial year is summarized below:

Amount in Rs.
Particulars For the Financial Year Ended 31.03.2016 For the Financial Year Ended 31.03.2015
Total Revenue 998420212 1065074377
Profit Before Financial Cost Depreciation Extraordinary Item and Tax 63443358 83082897
Less : Financial Cost 25984201 27007660
Profit Before Depreciation Extraordinary Item and Tax 37459157 56075237
Less : Depreciation 27277799 26716787
Profit Before Extraordinary Item and Tax 10181358 29358450
Less : Extraordinary Item 7976618 8725057
Profit Before Tax 2204740 20633393
Less : Tax 400000 4100000
Profit After Tax 1804740 16533393
Add : Brought Forward from Previous Year -34647478 -51180871
Closing Balance of Reserve & Surplus 26504461 -34647478

b. OPERATIONS:

During the financial year under review the turnover of your Company decreased by Rs66654165/- (Rupees Six Crores Sixty Six Lakh Fifty Four Thousand One Hundred Sixty Fiveonly).

You are hereby informed that there was a fire accident in the factory situated at AroorVillage Sadasivapet Mandal Medak District – 502 291 Telangana India involvingproduction Block – 2 extension (Pilot Plant) wherein fixed assets to the tune ofabout Rs. 2.2 crores and current assets to the tune of Rs.1.0 crores have been damaged on16.07.2015.

You are again hereby informed that there is adequate insurance coverage for both fixedassets and current assets.

Further the Company got adhoc release of Rs. 1.74 crores as part payment from NewIndia Insurance Company. The remaining balance is expected to release at the end of theAugust 2016.

There was no change in nature of the business of the Company during the year underreview.

c. REPORT ON PERFORMANCE OF SUBSIDIARIES ASSOCIATES AND JOINT VENTURE COMPANIES:

During the year under review your Company did not have any subsidiary associate andjoint venture company.

d. DIVIDEND:

With a view to conserve resources your Directors have thought it prudent to ploughback the entire profits and regret for not being able to recommend any dividend for thefinancial year under review.

e. TRANSFER TO RESERVES:

The Board of Directors has not recommended transfer of any amount of profit to reservesduring the year under review. Hence the entire amount of profit for the year under reviewhas been carried forward to the Profit and Loss Account.

f. REVISION OF FINANCIAL STATEMENTS:

There was no revision of the financial statements for the year under review.

g. DEPOSITS :

The Company has not accepted or renewed any amount falling within the purview ofprovisions of Section 73 of the Companies Act 2013 ("the Act") read with theCompanies (Acceptance of Deposit) Rules 2014 during the year under review. Hence therequirement for furnishing of details of deposits which are not in compliance with theChapter V of the Act is not applicable.

h. DISCLOSURES UNDER SECTION 134(3)(l) OF THE COMPANIES ACT 2013:

No material changes and commitments which could affect the Company’s financialposition have occurred between the ends of the financial year of the Company.

i. DISCLOSURE OF INTERNAL FINANCIAL CONTROLS

The Internal Financial Controls with reference to financial statements as designed andimplemented by the Company are adequate. During the year under review no material orserious observation has been received from the Internal Auditors of the Company forinefficiency or inadequacy of such controls. The Company maintains appropriate system ofinternal control including monitoring procedures to ensure that all assets aresafeguarded against loss from unauthorized use or disposition. Company policiesguidelines and procedures provide for adequate checks and balances and are meant toensure that all transactions are authorized recorded and reported correctly.

j. DISCLOSURE OF ORDERS PASSED BY REGULATORS OR COURTS OR TRIBUNAL:

The Company got restrictive order passed by the honorable National Green Tribunal (NGT)at Delhi regarding non – compliance in relation to zero liquidity dischargeenforced by Telangana State Pollution Control Board (TSPCB). However the full productionactivities restarted on 3rd December 2015 by means of an interim order by honorable NGT.However the Company got Consent for Operation (CFO) from TSPCB valid upto February2017.Final hearing at NGT is scheduled on 24.08.2017. And no other orders have been passedby any Regulator or Court or Tribunal which can have impact on the going concern statusand the Company’s operations in future.

k. PARTICULARS OF CONTRACTS OR ARRANGEMENT WITH RELATED PARTIES :

The details of transactions/contracts/arrangements entered into by the Company withrelated party(ies) as defined under the provisions of Section 2(76) of the Companies Act2013 during the financial year under review are furnished in DR - Annexure I and formspart of this Report.

l. PARTICULARS OF LOANS GUARANTEES INVESTMENTS AND SECURITIES:

No loans guarantees investments and securities provided during the financial yearunder review.

m. DISCLOSURE UNDER SECTION 43(a)(ii) OF THE COMPANIES ACT 2013:

The Company has not issued any shares with differential rights and hence no informationas per provisions of Section 43(a)(ii) of the Act read with Rule 4(4) of the Companies(Share Capital and Debenture) Rules 2014.

n. DISCLOSURE UNDER SECTION 54(1)(d) OF THE COMPANIES ACT 2013:

The Company has not issued any sweat equity shares during the year under review andhence no information as per provisions of Section 54(1)(d) of the Act read with Rule 8(13)of the Companies (Share Capital and Debenture) Rules 2014.

o. DISCLOSURE UNDER SECTION 62(1)(b) OF THE COMPANIES ACT 2013:

The Company has not issued any equity shares under Employees Stock Option Scheme duringthe year under review and hence no information as per provisions of Section 62(1)(b) ofthe Act read with Rule 12(9) of the Companies (Share Capital and Debenture) Rules 2014.

p. DISCLOSURE UNDER SECTION 67(3) OF THE COMPANIES ACT 2013:

During the year under review there were no instances of non-exercising of votingrights in respect of shares purchased directly by employees under a scheme pursuant toSection 67(3) of the Act read with Rule 16(4) of Companies (Share Capital and Debentures)Rules 2014.

q. CAPITAL REDUCTION SCHEME

The scheme for Capital Reduction was approved by the shareholders in the Annual GeneralMeeting dated 30.07.2014 and the same scheme has been approved by the High Court ofJudicature at Hyderabad on 22.06.2015. The Company has allotted the shares as per thescheme in the ratio 36:100 dated 17.08.2015 and the same has been listed with BombayStock Exchange.

r. CONVERSION OF LOAN INTO EQUITY CAPITAL OF THE COMPANY AND ALLOTMENT OF EQUITY SHARESAND CONVERTIBLE WARRANTS ON PREFERENTIAL BASIS :

During the year under review the Company has Rs. 9.05 crores as unsecured loan majorlyfunded by the Promoters of the Company when the Company was in financial distress from theyear 2000 onwards and so at that time company’s net worth became negative. Thereforethe Company filed its case with BIFR for registering as sick company in the year 2004 withthe case no. 36/2004. The Company was declared a sick industrial company in terms ofsection 3(1) (o) of the Sick Industrial Companies (Special Provisions) Act 1985 videBoard’s order dated 09.01.2006.

Further Board for Industrial and Financial Reconstruction (BIFR) Delhi Bench vide itsorder dated 24.06.2008 has abated the proceedings pending before the BIFR under the thirdprovision to section 15(1) of Sick Industrial Companies (Special Provisions) Act 1985 asthe ARCIL who was the sole creditor after taking over the debts of SBI ICICI and SBThaving more than 75% of the outstanding dues of the Company had taken symbolic possessionof the Company’s assets under section 13(4) of the SARFAESI Act.

To overcome with the tough situation promoters had to bring the funds in the Companyfor repayment and to sustain the business.

Further the Company has received letter from Kotak Mahindra Bank (the bankers) of theCompany vide their letter dated 07.03.2016 where they advised the Company to convert thesaid loan into the Equity Capital of the Company.

The Board of Directors of the Company has proposed for conversion of unsecured loaninto Equity Capital of the Company and for the same the Company seeks approval of themembers.

Further to cover up the losses and to make it profitable it required a large amount ofworking capital to carry day to day business and to purchase various required plant& Machineries.

Further being a manufacturing unit of pharmaceutical Bulk Drug again it required tocomply with the provisions of Pollution Control Board of Telangana which was again acostly affair for the Company.

For all the above mentioned reasons the promoters of Company have and other selectedpeople who are the employee of the Company brought the fund as unsecured loan into thecompany from time to time as and when it required.

Board of Directors at its meeting held on 30 th July 2016 after considering themaintaining public shareholding at 25% post issue deemed it appropriate to create issueoffer and allot equity shares to the following:

List of Allottees Amount in Rs.
Sl.No. Allottees No. of Equity Shares Allotment Price Amount including Premium
1. Veerat Finance Investment Limited 2711110 18/- 48799980
2. Sri Kakarlapudi Srihari Raju 1238890 18/- 22300020
Total 3950000

 

Sl.No. Allottees No. of Convertible Warrants Allotment Price Amount including Premium
1. Veerat Finance & Investment Limited 711720 18/- 12810960
Total 711720 18/- 12810960

Note : Presently for issuing of warrants upfront price is considering 25% ofallotment price.

s. Revocation of Suspension in Trading of Equity Shares of the Company :

The Company during the year under review got revocation order from suspension intrading of Equity Shares of the Company from Bombay Stock Exchange via Notice Dated :03.03.2016. And the trading in Equity share has started from 11.03.2016.

2. MATTERS RELATED TO DIRECTORS AND KEY MANAGERIAL PERSONNEL

a) BOARD OF DIRECTORS & KEY MANAGERIAL PERSONNEL

Mr. Sreeramakrishna Grandhi (DIN: 06921031) Dr. Srikakarlapudi Sirisha (DIN: 06921012)who were appointed on 30.07.2014 and Mr. Reddy Eashwer Kanthala (DIN : 02327979) who wereappointed on 31st August 2015 as Additional Directors of the Company to hold office upto the date of ensuing Annual General Meeting were regularized as a Director of theCompany on the 22nd Annual General Meeting held on 28.09.2015.

Further the Board has recommended in their meeting held on 30.07.2016 to appoint Mr.Sri Kakarlapudi Harikrishna as a Wholetime Director in the Company with effect from29.08.2016.

b) APPOINTMENT OF INDEPENDENT DIRECTORS:

Mr. Sreeramakrishna Grandhi (DIN: 06921031) Mr. Ramakrishnam Raju Kounparaju (DIN:01735481) and Mr. Swaminathan Venkatesan (DIN: 02810646) were appointed as IndependentDirectors of the Company for a period of 4 years w.e.f 31.08.2015.

In accordance with the provisions of the Act none of the Independent Directors isliable to retire by rotation.

c) DECLARATIONS BY INDEPENDENT DIRECTORS:

The Company has received declarations from all the Independent Directors under Section149(6) of the Companies Act 2013 confirming their independence vis--vis the Company.

d) RE-APPOINTMENT OF DIRECTORS RETIRE BY ROTATION

As per the provisions of Section 152 of the Companies Act 2013 Mr. Akella Parvatisem(DIN : 00910224) and Dr. Sri Kakarlapudi Sirisha (Din : 06921012) will retire by rotationat the ensuing Annual General Meeting and being eligible offer themselves forre-appointment.

Your Directors recommend their candidature for approval.

3. DISCLOSURES RELATED TO BOARD COMMITTEES AND POLICIES

a. BOARD MEETINGS:

The Board of Directors met 11 times during the financial year ended 31st March 2016 inaccordance with the provisions of the Companies Act 2013 and rules made there under.

The dates on which the Board of Directors met during the financial year under revieware as under:

Sl. No. Day Date
1 Saturday 30.05.2015
2 Wednesday 10.06.2015
3 Thursday 30.07.2015
4 Monday 17.08.2015
5 Monday 31.08.2015
6 Monday 28.09.2015
7 Monday 26.10.2015
8 Thursday 12.11.2015
9 Tuesday 15.12.2015
10 Friday 22.01.2016
11 Thursday 31.03.2016

b. DIRECTOR’S RESPONSIBILITY STATEMENT:

In terms of Section 134(5) of the Companies Act 2013 in relation to the auditedfinancial statements of the Company for the year ended 31st March 2016 the Board ofDirectors hereby confirms that:

a. in the preparation of the annual accounts the applicable accounting standards hadbeen followed along with proper explanation relating to material departures;

b. such accounting policies have been selected and applied consistently and theDirectors made judgments and estimates that are reasonable and prudent so as to give atrue and fair view of the state of affairs of the Company as at 31st March 2016 and ofthe profit/loss of the Company for that year;

c. proper and sufficient care was taken for the maintenance of adequate accountingrecords in accordance with the provisions of this Act for safeguarding the assets of theCompany and for preventing and detecting fraud and other irregularities;

d. the annual accounts of the Company have been prepared on a going concern basis;

e. internal financial controls have been laid down to be followed by the Company andthat such internal financial controls are adequate and were operating effectively;

f. proper systems have been devised to ensure compliance with the provisions of allapplicable laws and that such systems were adequate and operating effectively;

c. NOMINATION AND REMUNERATION COMMITTEE:

The Nomination and Remuneration Committee of Directors as constituted by the Board ofDirectors of the Company in accordance with the requirements of Section 178 of the Act.

The composition of the committee is as under:

1. Mr. Ramakrishnam Raju Kounparaju (DIN : 01735481) Director

2. Mr. Swaminathan Venkatesan (DIN : 02810646) Director and

3. Mr. Sreeramakrishna Grandhi (DIN: 06921031) Chairman

The Board has in accordance with the provisions of sub-section (3) of Section 178 ofthe Companies Act 2013 formulated the policy setting out the criteria for determiningqualifications positive attributes independence of a Director and policy relating toremuneration for Directors Key Managerial Personnel and other employees.

d. AUDIT COMMITTEE:

The Audit Committee of Directors was constituted pursuant to the provisions of Section177 of the Companies Act 2013. The composition of the Audit Committee is in conformitywith the provisions of the said section. Mr. Sreeramakrishna Grandhi Independent Directorof the Company has been appointed as a member of Audit Committee on 22.01.2016. The AuditCommittee comprises of:

1. Mr. Sreeramakrishna Grandhi (DIN: 06921031) Chairman from 22.01.2016

2. Mr. Ramakrishnam Raju Kounparaju (DIN : 01735481) Chairman till 22.01.2016

3. Mr. Swaminathan Venkatesan (DIN : 02810646) Independent Director and

4. Mr. Akella Parvatisem (DIN: 00910224) Director.

The scope and terms of reference of the Audit Committee have been amended in accordancewith the Act and the Listing Agreement entered into with the Stock Exchanges.

During the year under review the Board of Directors of the Company had accepted allthe recommendations of the Committee.

The dates on which the members of the Audit Committee met during the financial yearunder review are as under:

Sl. No. Day Date
1 Saturday 30.05.2015
2 Thursday 30.07.2015
3 Monday 26.10.2015
4 Friday 22.01.2016

e. STAKEHOLDERS RELATIONSHIP COMMITTEE:

During the year under review pursuant to Section 178 of the Companies Act 2013 theBoard of Directors of the Company has constituted the Stakeholder’s RelationshipCommittee comprising Mr. Srikakarlapudi Harikrishna Mr. V. Swaminathan and Mr. A.Parvatisem Directors of the Company.

Mr. Swaminathan Venkatesan is the Chairman of the Committee. The Company Secretaryacts as the Secretary of the Committee.

f. VIGIL MECHANISM POLICY FOR THE DIRECTORS AND EMPLOYEES:

The Board of Directors of the Company has pursuant to the provisions of Section 178(9) of the Companies Act 2013 read with Rule 7 of the Companies (Meetings of Board andits Powers) Rules 2014 framed "Vigil Mechanism Policy" for Directors andemployees of the Company to provide a mechanism which ensures adequate safeguards toemployees and Directors from any victimization on raising of concerns of any violations oflegal or regulatory requirements incorrect or misrepresentation of any financialstatements and reports etc.

The employees of the Company have the right/option to report their concern/grievance tothe Chairman of the Audit Committee.

The Company is committed to adhere to the highest standards of ethical moral and legalconduct of business operations.

g. RISK MANAGEMENT POLICY :

The Board formulated and implemented Risk Management Policy for the Company whichidentifies various elements of risks which in its opinion may threaten the existence ofthe Company and measures to contain and mitigate risks. The Company has adequate internalcontrol systems and procedures to combat the risk. The Risk Management procedures arereviewed by the Board on quarterly basis at the time of review of performance of theCompany.

h. CORPORATE SOCIAL RESPONSIBILITY POLICY:

As per the provisions of Section 135 of the Act read with Companies (Corporate SocialResponsibility Policy) Rules 2014 the Board of Directors has constituted a CorporateSocial Responsibility (CSR) Committee as under:

1. Mr. A. Parvatisem Chairman

2. Mr. S. K. Harikrishna

3. Mr. G.S.S.R Sarma and

4. Mr. CH. Ramesh

The Board of Directors of the Company has approved CSR Policy based on therecommendation of the CSR Committee. The Company has initiated activities in accordancewith the said Policy but your Company does not fall in the applicable criteriaincorporated under the provisions of Companies Act 2013.

i. ANNUAL EVALUATION OF DIRECTORS COMMITTEE AND BOARD:

A formal evaluation mechanism has been adopted for evaluating the performance of theBoard as well as performance of Committees and individual Directors. Performance of allDirectors and the Company has been carried out by way of structured evaluation process.Criteria for evaluation includes attendance and contribution at the meetings preparednessfor the meetings effective decision making ability etc.

j. INTERNAL CONTROL SYSTEMS:

Adequate internal control systems commensurate with the nature of the Company’sbusiness size and complexity of its operations are in place and have been operatingsatisfactorily. Internal control systems comprising policies and procedures are designedto ensure reliability of financial reporting timely feedback on achievement ofoperational and strategic goals compliance with policies procedures applicable laws andregulations and that all assets and resources are acquired economically used efficientlyand adequately protected.

k. DISCLOSURE UNDER SECTION 197(12) OF THE COMPANIES ACT 2013 AND OTHER DISCLOSURES ASPER RULE 5 OF COMPANIES (APPOINTMENT & REMUNERATION) RULES 2014:

The ratio of the remuneration of each Director to the median remuneration of theemployees of the Company for the financial year under review has been marked as DR -Annexure ll.

l. PAYMENT OF REMUNERATION / COMMISSION TO DIRECTORS FROM HOLDING OR SUBSIDIARYCOMPANIES:

Not Applicable as the Company has no holding or Subsidiary entity.

4. AUDITORS AND REPORTS

The matters related to Auditors and their Reports are as under:

a. OBSERVATIONS OF STATUTORY AUDITORS ON ACCOUNTS FOR THE YEAR ENDED 31ST MARCH 2016:

The observations made by the Statutory Auditors in their report for the financial yearended 31st March 2016 read with the explanatory notes therein are self-explanatory andtherefore do not call for any further explanation or comments from the Board underSection 134(3) of the Companies Act 2013.

b. SECRETARIAL AUDIT REPORT FOR THE YEAR ENDED 31ST MARCH 2016:

Provisions of Section 204 read with Section 134(3) of the Companies Act 2013 mandatesto obtain Secretarial Audit Report from Practicing Company Secretary. D. Hanumanta Raju& Co. Company Secretaries of B-13 F-1 P.S. Nagar Vijayanagar Colony Hyderabad– 500 057India had been appointed to issue Secretarial Audit Report for thefinancial year 2015-16.

Secretarial Audit Report issued by D. Hanumanta Raju & Co. Company Secretaries ofB-13 F-1 P.S. Nagar Vijayanagar Colony Hyderabad – 500 057India CompanySecretaries in Form MR-3 for the financial year 2015-16 forms part of this report as DR -Annexure lll. The said report is self explanatory.

c. APPOINTMENT OF STATUTORY AUDITORS:

Pursuant to the provisions of Section 139 of the Companies Act 2013 and the Companies(Audit and Auditors) Rules 2014 M/s P.S. N. Ravi Shankar & Associates CharteredAccountants the Statutory Auditors of the Company they have been re-appointed for a termof two financial years 2015 - 2016 and 2016 – 2017 on 22nd Annual General Meeting tohold office till the Annual General Meeting of 2017. The consent of the Auditors alongwith the certificate under Section 139 of the Act has been obtained to the effect thattheir appointment in the Financial Year 2016-2017 in accordance with the prescribedconditions and that they were eligible to hold the office of Auditors of the Company. TheBoard recommends to ratify the appointment of M/s. P.S. N. Ravi Shankar & AssociatesChartered Accountants as the Statutory Auditors of the Company for the Financial Year2016-2017.

Necessary resolution for ratification of the said Auditors is included in the Notice ofAGM for seeking approval of members.

d. COST AUDITORS:

Pursuant to the provisions of Section 148 of the Companies Act 2013 read withNotifications/Circulars issued by the Ministry of Corporate Affairs from time to time asper the recommendation of the Audit Committee the Board of Directors at their meetingdated 30.07.2015 appointed M/s Sativada Venkat Rao Cost Accountants as the Cost Auditorsof the Company for the financial year 2015-16 in respect of the Company’s pharmamanufacturing units at Aroor Village Sadasivapet Medak District Telangana – 502291. The Cost Audit Report will be filed within the stipulated period of 180 days from theclosure of the financial year subject to the availability of respective e-forms at MCASites.

5. OTHER DISCLOSURES

Other disclosures as per provisions of Section 134 of the Act read with Companies(Accounts) Rules 2014 are furnished as under:

a. EXTRACT OF ANNUAL RETURN:

Pursuant to the provisions of Section 134(3)(a) of the Companies Act 2013 Extract ofthe Annual Return for the financial year ended 31st March 2016 made under the provisionsof Section 92(3) of the Act is attached as DR - Annexure lV which forms part of thisReport.

b. CONSERVATION OF ENERGY TECHNOLOGY ABSORPTION AND FOREIGN EXCHANGE EARNINGS ANDOUTGO:

The particulars as required under the provisions of Section 134(3) (m) of the CompaniesAct 2013 read with Rule 8 of the Companies (Accounts) Rules 2014 in respect ofconservation of energy and technology absorption foreign exchange earnings and outgo etc.are furnished in as per DR - Annexure V considering the nature of activities undertaken bythe Company during the year under review which forms part of this report.

c. Information under the Sexual Harassment of Women at Workplace (PreventionProhibition and Redressal) Act 2013:

The Company has constituted an Internal Compliant Committee under Section 4 of theSexual Harassment of Women at Workplace (Prevention Prohibition and Redressal) Act 2013.During the year no complaint was made before the Committee.

d. CORPORATE GOVERNANCE: (Applicable to Companies giving remuneration as per Section IIof Schedule V) :

Amount in Rs.
All elements of remuneration package such as salary benefits bonuses stock options pension etc. of all the directors Salary INR 5025000/-
Details of fixed component and performance linked incentives along Fixed Component
with the performance criteria Salary – 5025000/-
Service contracts notice period severance fees No Such terms are there.
Stock option details if any and whether the same has been issued at a discount as well as the period over which accrued and over which exercisable As may be decided

e. NON APPLICABILITY OF CORPORATE GOVERNANCE REPORT

During the Financial year under review as per Regulation 15(2) of SEBI (ListingObligations & Disclosure Requirements) Regulations 2015 the Regulation 27 of the saidRegulation is not applicable to the Company as the Company’s Paid up capital is lessthan Rupees Ten Crores and the Net Worth of the Company does not exceed Rupees Twenty FiveCrores as on the last day of previous financial year.

f. PERSONNEL:

The Company enjoys a harmonious and healthy relationship with personnel at all levels.

Particulars of employees in terms of the Companies Act 2013 are not applicable as noemployee is drawing salary in excess of limits prescribed by the Companies Act 2013.

6. ACKNOWLEDGEMENTS AND APPRECIATION:

Your Directors take this opportunity to thank the customers shareholders suppliersbankers business partners/associates financial institutions and Central and StateGovernments for their consistent support and encouragement to the Company.

For and on behalf of the Board
Everest Organics Limited
Rama Krishnam Raju Kounparaju Dr. Sri Kakarlapudi Srihari Raju
Chairman Managing Director
DIN: 01735481 DIN : 01593620
Dated : 30.07.2016
Registered Office
Aroor Village
Sadasivapet Mandal
Medak District – 502 291
Telangana India
CIN L24230AP1993PLC015426
TEL No. 040-23115956 Fax No. 040-23115954
Mail eolcs0405@gmail.com website: www.everestorganicsltd.com